Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,458,023
  • Shares Outstanding, K 48,375
  • Annual Sales, $ 399,250 K
  • Annual Income, $ -30,440 K
  • 60-Month Beta 1.39
  • Price/Sales 3.52
  • Price/Cash Flow N/A
  • Price/Book 2.87
Trade ATRC with:

Options Overview Details

View History
  • Implied Volatility 60.79% ( -3.36%)
  • Historical Volatility 44.45%
  • IV Percentile 78%
  • IV Rank 62.24%
  • IV High 91.88% on 02/01/24
  • IV Low 9.55% on 05/17/23
  • Put/Call Vol Ratio 4.33
  • Today's Volume 16
  • Volume Avg (30-Day) 89
  • Put/Call OI Ratio 1.50
  • Today's Open Interest 2,623
  • Open Int (30-Day) 2,602

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.21
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +13.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.92 +8.95%
on 03/25/24
39.04 -22.09%
on 03/07/24
-3.54 (-10.42%)
since 02/28/24
3-Month
27.92 +8.95%
on 03/25/24
39.04 -22.09%
on 03/07/24
-6.31 (-17.18%)
since 12/28/23
52-Week
27.92 +8.95%
on 03/25/24
59.61 -48.97%
on 07/26/23
-10.22 (-25.15%)
since 03/28/23

Most Recent Stories

More News
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 30.42 (+0.93%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 30.42 (+0.93%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 30.42 (+0.93%)
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of 32.35% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 30.42 (+0.93%)
ZVIA : 1.1700 (+11.43%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 30.42 (+0.93%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 30.42 (+0.93%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 30.42 (+0.93%)
AtriCure to Announce First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 30.42 (+0.93%)
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 30.42 (+0.93%)
AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last?

AtriCure (ATRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ATRC : 30.42 (+0.93%)
PHG : 20.00 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 31.77
2nd Resistance Point 31.17
1st Resistance Point 30.80
Last Price 30.42
1st Support Level 29.83
2nd Support Level 29.23
3rd Support Level 28.86

See More

52-Week High 59.61
Fibonacci 61.8% 47.50
Fibonacci 50% 43.76
Fibonacci 38.2% 40.03
Last Price 30.42
52-Week Low 27.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar